Pyeongtaek Manufacturing Center Earns Top PSM Rating from Ministry of Employment and Labor
Secures "P Grade" Again This Year, Following 2022 Achievement

Hanmi Group's Pyeongtaek Manufacturing Center, its global biopharmaceutical production base, has proven its safety management system and capabilities.


On July 31, Hanmi Pharm announced that its Pyeongtaek Manufacturing Center received the highest "P grade" in the regular Process Safety Management (PSM) implementation assessment conducted by the Ministry of Employment and Labor this year. This marks the second consecutive time that the center has received the top grade, following its P grade in 2022—making it the first in the pharmaceutical and biotechnology sector to achieve this milestone twice in a row.


Interior view of Hanmi Pharm Pyeongtaek Bio Plant. Hanmi Pharm

Interior view of Hanmi Pharm Pyeongtaek Bio Plant. Hanmi Pharm

View original image

The PSM system is a Ministry of Employment and Labor program that comprehensively evaluates the safety management standards of workplaces handling hazardous facilities and harmful substances, aiming to prevent major industrial accidents.


The Pyeongtaek Manufacturing Center has operated its workplace safety management system by advancing risk assessments, proactively identifying harmful and hazardous factors, strengthening site-oriented safety activities, and promoting a culture of safety. The company's efforts to firmly establish a field-based, prevention-focused safety management system were also highly recognized.


Hanmi Pharm continues to strengthen its Environmental, Health, and Safety (EHS) management systems at its main sites, including the Pyeongtaek Manufacturing Center and the Paltan Manufacturing Center. Through data-driven safety management activities and a prevention-centered system, the company strives to establish a globally competitive safety management framework and enhance its manufacturing competitiveness.



Kim Sae-kwon, Managing Director and Head of the Pyeongtaek Manufacturing Center at Hanmi Pharm, stated, "This achievement is the result of all employees consistently prioritizing and practicing safety as their foremost value. Going forward, we will further strengthen proactive risk management and systematic safety management activities to create an accident-free workplace and enhance global competitiveness based on a safe production environment."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing